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Abstract
We report the case of a 60-year-old woman, presenting with left vocal cord
paralysis (VCP). Diagnostic evaluation revealed sarcoidosis to be the underlying pathology. Computed tomography (CT) scans exhibited enlarged subcarinal, pretracheal, and prevascular lymph nodes as the possible
mechanism of left VCP through compression of the left recurrent laryngeal
nerve. Initial treatment with oral prednisolone and azathioprine led to
remission of symptoms; however, tapering of dosage led to relapse of cough
without any signs of VCP. The dosage of prednisolone was further boosted,
leading to complete remission. A review of literature reveals 20 cases have
been reported to date, with all but one involving the left vocal cord. This is
the ﬁrst reported case, with a relapse of the disease without a relapse of
VCP, indicating the rarity of sarcoidosis-associated VCP.

doi: 10.1002/rcr2.705

Introduction
Sarcoidosis is a multisystemic disease of unknown
aetiology which often involves multiple organs, most commonly the lungs and lymph nodes. We report an interesting case, which initially presented as hoarseness of voice
accompanied with cough, weight loss, and enlarged mediastinal lymph nodes. Following the diagnosis on mediastinoscopic lymph node biopsy, the patient was started on
corticosteroid therapy with signiﬁcant improvement; however, tapering of steroid dosage led to relapse of symptoms,
without a relapse of the vocal cord palsy.

Case Report
A 60-year-old, non-smoker, female, known case of hypertension, presented to the Ear, Nose & Throat (ENT) clinic
with a history of hoarseness of voice, signiﬁcant weight
loss, and chronic cough for the past six weeks. The cough
was dry initially, although at the time of presentation it
turned productive of mucoid sputum. The coughing episodes were signiﬁcantly more prevalent during night, and
there was associated shortness of breath on exertion. She
also reported a persistent globus sensation and difﬁculty in

swallowing. There was no history of fever, night sweats,
rheumatological symptoms, and chronic gastroesophageal
reﬂux or post nasal drip symptoms. Furthermore, she
reported positive exposure to biomass fuel during her
childhood; however, exposure to pets was unremarkable.
She was treated with montelukast and levoﬂoxacin for
suspected upper respiratory tract infection; however, this
regimen did not improve her symptoms.
The patient’s blood pressure measured 139/70 mmHg,
pulse 76/min, temperature 37.1 C, respiratory rate of
17 breaths/min, and arterial oxygen saturation (SpO2) of
97%. Chest examination revealed bilateral vesicular breath
sounds with no added sounds. The rest of the systemic
and general examination was unremarkable.
A bronchoscopy performed outside our institution was
unremarkable and a bronchoalveolar lavage (BAL) was
negative for Acid-Fast Bacilli (AFB) smear, Gene Xpert,
and fungal cultures. The serum angiotensin-converting
enzyme (ACE) was 48 IU/L (reference range: 0–52/IU/L).
Pulmonary functional test (PFT) demonstrated the presence of a signiﬁcant restrictive pathology, with forced vital
capacity (FVC) being 52% of the predicted value, forced
expiratory volume in 1 sec (FEV1) 55% of predicted, and
FEV1/FVC ratio being 77%.
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The patient underwent ﬂexible ﬁbre-optic laryngoscopy
which showed a ﬁxed left vocal cord, with no lesion identiﬁed. A computed tomography (CT) scan with contrast of
the thorax revealed bilateral perihilar ill-deﬁned
opaciﬁcation with multifocal scattered alveolar and nodular inﬁltrates. Enlarged mediastinal lymph nodes
(prevascular, pretracheal, paracardiac, and subcarinal) with
calciﬁcations were also noted, with the largest lymph node
in the subcarinal location, measuring approximately
12 mm in the short-axis diameter (Fig. 1). There was no
evidence of any extra-thoracic lesions. A CT-guided core
lung biopsy revealed peri-bronchial non-necrotizing granulomatous lesions. A diagnosis of pulmonary sarcoidosis
with left vocal cord paralysis (VCP) was made. Due to
ﬁnancial constraints, and reasonable clinical conﬁdence in
diagnosis, a ﬂuorodeoxyglucose–positron emission tomography (FDG–PET) was not performed. The patient was
started on oral prednisolone at 0.5 mg/kg/day.
She responded well to corticosteroid therapy with complete resolution of symptoms. A follow-up PFT, two
months post-initiation of therapy, showed markedly
improved pulmonary function with FVC being 71% of
predicted, FEV1 71% of predicted, and FEV1/FVC ratio
being 81%. The corticosteroid therapy was tapered to a
maintenance dose of 5 mg/day and the patient was started
on azathioprine (100 mg/day).
The patient presented with relapse of symptoms of
cough within few weeks of maintenance therapy. The
patient denied any presence of dysphonia or hoarseness of
voice. Repeat PFTs revealed marked deterioration, with
FVC being 63% of predicted, FEV1 57% of predicted, and
FEV1/FVC ratio being 91% predicted. A high-resolution
CT (HRCT) chest revealed an ill-deﬁned bilateral, perihilar
patchy opaciﬁcation with multifocal scattered alveolar/
nodular inﬁltrates demonstrating mild interval progression
in the right perihilar region, along with enlarged calciﬁed
mediastinal lymph nodes (including the paracardiac lymph

nodes). The patient was again started on 30 mg/day prednisolone and this resulted in signiﬁcant improvement of
symptoms. To prevent further relapse, another immunosuppressant (mycophenolate: 1000 mg/day) was added to
the treatment regimen. Once the patient started showing
clinical improvement, the corticosteroid therapy was gradually tapered to a maintenance dosage 2.5 mg/day.

Discussion
Sarcoidosis is a complex, multisystem, granulomatous disease of unknown aetiology, ranging from asymptomatic to
life-threatening manifestations. It commonly involves the
lung parenchyma, seen in up to 90% of patients [1]. Laryngeal manifestations of the disease remain rare, with
reported incidence between 0.5% and 8.3% [2].
Among the potential laryngeal manifestations, supraglottic and subglottic involvement is usually implicated,
with disease rarely affecting the true vocal cords [2]. Literature has shown three mechanisms involved with the
development of VCP in sarcoidosis [3–7]. The ﬁrst mechanism involves direct invasion of vocal cords by granulomatous tissue. This is considerably rare as the spread of
sarcoidosis is mediated through the reticuloendothelial system and the true vocal cords are devoid of lymphatics. At
present, only two cases of VCP due to direct invasion are
reported in literature [2,5]. In both cases, the direct invasion of granulomatous tissue affected both true vocal
cords. Subglottic and supraglottic areas were also involved,
suggesting contiguous spread to the true vocal cords from
these areas. The second mechanism is a rare manifestation
of sarcoidosis, known as neurosarcoidosis, whereby there
is presence of polyneuritis of the cranial nerves. The third
mechanism relates to the compression of the recurrent
laryngeal nerves by enlarged mediastinal lymph nodes.
This is the most common mechanism reported in 12 out of
19 cases of sarcoidosis with VCP [2,4,5]. The aetiology in

Figure 1. (A) Computed tomography (CT) scan of the chest mediastinal window displaying enlarged, calciﬁed subcarinal lymph node. (B) Lung window showing right-sided lung parenchymal inﬁltrates.

2

© 2020 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd
on behalf of The Asian Paciﬁc Society of Respirology

74/Female
64/Male

Wigan, UK

Barcelona, Spain

Minnesota, USA
Virginia, USA

Plymouth, UK
Jerusalem, Israel

Mastan et al./2015 [6]

Lop Gros et al./2014 [7]

Sekiguchi et al./2013 [9]
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Boyd et al. /2011 [8]

Hughes and
McGavin/1995 [10]
Jaffe et al./1994 [11]

45/Male

60/Female

35/Female

40/Female

51/Female

New York, USA

Wu et al./2019 [4]

60/Female

Age/gender

Karachi, Pakistan

Location

Current case/2020

Author/year

Table 1. Reported cases of sarcoidosis-associated unilateral VCP.

Left

Left

Right

Left

Left

Left

Left

Left

Vocal cord
paralysed

Compressive
lymphadenopathy
Compressive
lymphadenopathy

Compressive
lymphadenopathy
Compressive
lymphadenopathy

Compressive
lymphadenopathy

Left recurrent laryngeal
nerve
neurosarcoidosis

Left vagal
neurosarcoidosis

Compressive
lymphadenopathy

Aetiology

Permanent resolution of
LVCP

Persistence of
lymphadenopathy
Permanent resolution of
LVCP after eight weeks

Response

Prednisone
Initial dose of 60 mg/day
tapered over eight
months

Persistence of
lymphadenopathy
Persistence of LVCP after
32 weeks

Persistence of LVCP due
to stoppage of
corticosteroid therapy
after four weeks
Prednisone 1 mg/kg/day for Resolution of
six months
lymphadenopathy
Persistence of LVCP after
24 weeks
Prednisone 40 mg/day
Persistence of LVCP
tapered over two years
Complete resolution of
Oral steroids for two
RVCP following
months followed by
paratracheal
paratracheal
lymphadenectomy
lymphadenectomy
N/A
N/A

Prednisolone
0.5 mg/kg/day tapered over
nine months to a
maintenance dose of
2.5 mg/day
Steroids + left injection
laryngoplasty with 2 mL
of micronized dermis
Prednisolone 40 mg/day
tapered to 20 mg/day
over six weeks

Treatment
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Prednisolone
30 mg/day
Left

LVCP, left VCP; RVCP, right VCP; VCP, vocal cord paralysis.

17/Male
Chijimatsu et al./1980 [15] Tokyo, Japan

Compressive
lymphadenopathy

Prednisolone
40 mg/day
Compressive
lymphadenopathy
Left

Left
49/Male
Los Angeles, USA

el-Kassimi et al. /1990 [14] Riyadh, Saudi Arabia 45/Female

Prednisone 40 mg/day

Complete resolution after
six weeks
Resolution of
lymphadenopathy
Permanent Resolution of
LVCP
Resolution of
lymphadenopathy
Permanent resolution of
LVCP after 1.5 weeks
Permanent resolution of
LVCP after 2.5 weeks
Prednisone

Compressive
lymphadenopathy
Compressive
lymphadenopathy
Left
53/Male
N/A

Povedano Rodríguez
et al./1992 [12]
Tobias et al./1990 [13]

Author/year

Table 1. Continued

Location

Age/gender

Vocal cord
paralysed

Aetiology

Treatment

Response

Sarcoidosis with vocal cord palsy

our case also favours compressive lymphadenopathy due to
enlarged paracardiac lymph nodes. Direct invasion of vocal
cords was excluded in our case due to lack of any lesion or
presence of granulation tissue visualized through ﬂexible
ﬁbre-optic laryngoscopy. Previous reports of neurosarcoidosis used magnetic resonance imaging (MRI) scans
to diagnose neurosarcoidosis, which is the most sensitive
modality [4]. In the current case, while neurosarcoidosis
could not be excluded completely (due to lack of MRI stemming from ﬁnancial concerns), this diagnosis remained
unlikely due to the lack of any aberrant cranial neve or central nervous system (CNS) signs and symptoms or any CNS
lesions visualized through CT imaging of the brain.
VCP may be unilateral or bilateral. Left VCP (LVCP) is
most commonly reported, due to external compression of
the recurrent laryngeal nerves. The left recurrent laryngeal
nerve is longer than the right (12 vs. 6 cm) as it loops
around the arch of the aorta and is more likely to be compressed by the mediastinal lymph nodes that are enlarged
in sarcoidosis [6]. On the other hand, the right recurrent
laryngeal nerve courses around the right subclavian artery
and is less likely to be compressed. To date, only a single
case has been reported with isolated right VCP (RVCP),
with the suspected cause being compression of the right
recurrent laryngeal nerve from the right para-tracheal
lymph nodes [8]. Among the three listed causes of VCP,
only two, compressive lymphadenopathy and vagal neurosarcoidosis, have been implicated in unilateral VCP
(Table 1).
Bilateral VCP (BVCP) is less common than unilateral
VCP, with eight reported cases in literature [4,5]. BVCP is
signiﬁcantly more dangerous than unilateral VCP as it
may lead to critical airway compromise, as reported by
Hintze et al. [5]. Among the reported cases of BVCP, three
were due to bilateral vagal neurosarcoidosis, three were
due to compressive lymphadenopathy, and two were due
to bilateral direct granulomatous invasion (Table 2).
A review of literature reveals that the average age of presentation is 49, with 60% of patients being female (12 out
of 20 cases). Left vocal cord involvement has been present
in all but one case of sarcoidosis-associated VCP (19 out
of 20 cases).
For pulmonary sarcoidosis, systemic glucocorticoids
remain the mainstay ﬁrst-line therapy [18]. As per consensus statement by the American Thoracic Society, European
Respiratory Society, and World Association of Sarcoidosis
and Other Granulomatous Disorders, the initial dose is
20–40 mg/day with eventual tapering, and discontinuation
of therapy in 6–12 months [19]. In some cases, a maintenance dose is required for longer duration, as in our case
to prevent relapse of symptoms. Even after corticosteroid
therapy, vocal cord palsy may persist with resolution of
symptoms with persistence of VCP being reported in seven
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Arizona, USA

Oita, Japan

Barcelona, Spain

Pennsylvania, USA 35/Male

Hintze et al./2018 [5]

Yamasue et al./2016 [3]

Lop Gros et al./2014 [7]
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Coffey et al./2009 [16]

41/Female

Witt/2003 [17]

Both

Both

Both

Both

Both

Both

Both

Both

BVCP, bilateral VCP; LVCP, left VCP; RVCP, right VCP; VCP, vocal cord paralysis.

Delaware, USA

41/Female

Rupanagudi et al./2005 [2] New York, USA

61/Female

72/Female

49/Female

37/Male

New York, USA

Wu et al./2019 [4]

48/Male

Vocal cord
Age/gender paralysed

New York, USA

Location

Wu et al./2019 [4]

Author/year

Table 2. Reported cases of sarcoidosis-associated BVCP.

Bilateral direct
granulomatous
inﬁltration
Cranial polyneuritis and
compressive
lymphadenopathy

Bilateral compressive
lymphadenopathy

Bilateral compressive
lymphadenopathy

Bilateral vagal
neurosarcoidosis

Bilateral direct
granulomatous
inﬁltration

Bilateral vagal
neurosarcoidosis

Bilateral vagal
neurosarcoidosis

Aetiology

Persistence of BVCP
after four years

Persistence of BVCP
after 32 weeks

Resolution of BVCP
following
laryngoplasty

Response

Methylprednisolone 160 mg/day

Complete resolution of
BVCP after one
week

Complete resolution of
BVCP after
16 weeks
Prednisone 1 mg/kg/day for three Resolution of LVCP
months
after 12 weeks,
persistence of RVCP
Methylprednisolone 1 g/day
Complete resolution of
followed by prednisone 40 mg/
BVCP after two
day
weeks
Oral steroids for three months
Complete resolution of
BVCP

Prednisone 50 mg/day followed
by bilateral injection
laryngoplasties with 2 mL of
micronized dermis
Injection laryngoplasty with 2 mL
of micronized dermis, followed
by left medialization
laryngoplasty
Tracheostomy, Radiesse injection
(Merz Aesthetics, Inc.,
Frankfurt, Germany),
methylprednisolone 40 mg/day
followed by prednisolone
40 mg/day tapered over six
months
Prednisone (30 mg/day) tapered to
15 mg/day over four months

Treatment
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out of 20 cases. In the seven cases of persistence, four were
cases of LVCP, two were cases of BVCP, and one was a
case of partially treated sarcoidosis associated BVCP where
the RVCP persisted. In cases of recurrence or persistence
of the vocal cord palsy, it is important for the physician to
consider the aetiology of the vocal cord palsy. Surgical
measures, such as lymphadenectomy, may be required to
improve the quality of life. Boyd et al. reported a case of
unilateral RVCP,
which was cured following
lymphadenectomy, as the compressive force on the right
recurrent laryngeal nerve was relieved [8]. Less invasive
measures such as laryngoplasty with injection of micronized dermis and speech and language therapy have also
proven useful in improving the dysphonia [4,6].
In our case, the patient initially responded well to the
corticosteroid therapy, with complete resolution of
symptoms. However, on maintenance dosage of prednisolone, there was relapse of disease. Interestingly, there
was no relapse of the left vocal cord palsy. This is in
spite of the repeat HRCT scan showing enlarged, calciﬁed mediastinal lymph nodes (including paracardiac
lymph nodes) that may have possibly compressed the left
recurrent laryngeal nerve. This is particularly unusual as
the presumptive cause of the initial LVCP had been compression of the left recurrent laryngeal nerve by enlarged
mediastinal lymph nodes (primarily by the paracardiac
lymph nodes), which remained persistent. In all previous
cases of treated LVCP (due to compressive lymphadenopathy), resolution of lymphadenopathy leads to resolution of the LVCP.
In conclusion, we report a case of sarcoidosis associated with LVCP which resolved following oral corticosteroid therapy despite persistence of enlarged
mediastinal lymph nodes and later relapse of the disease.
The above literature demonstrates that sarcoidosisassociated VCP remains an exceedingly rare presentation, it must be recognized and appropriately managed
by clinicians.
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